Will 2020 see the debut of promising gene therapy for hemophilia A? It’s up to the FDA.
“Jon Entine was truly an incredible and captivating speaker. A must see and hear phenomenon.”— Diane Scar, Jewish National Fund
Reach out to explore availability!